Catalyst Wire Dossier Catalyst Wire Dossier

urinary kallikrein

urinary kallikrein
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for urinary kallikrein, covering 2020-03-30 to 2020-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis [Phase 4]

See pricing